Published in Gene Therapy Weekly, May 9th, 2002
Merck & Co., Inc., and Schering-Plough Research Institute will continue to utilize the Transfac Professional Suite's in-depth gene regulation information.
In addition to the vast transcription factor data, the suite now includes composite regulatory element information, and mutant factor and binding site data, creating a robust gene regulation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.